The Flavonol Quercitrin Inhibits GSK3 Activity and Enhances the Wnt/β-Catenin Signaling Pathway

    Danilo Predes, Lorena Agostini Maia, Isadora Matias, Hannah P. Mota-Araujo, Carolina Soares, Fernanda G. Q. Barros‐Aragão, Luiz Fernando Silva Oliveira, Renata Rodrigues dos Reis, Nathália G. Amado, Alessandro B. C. Simas, Fábio A. Mendes, Flávia Carvalho Alcântara Gomes, Cláudia P. Figueiredo, José G. Abreu
    TLDR Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.
    The study identified quercitrin, a flavonol, as a novel enhancer of the Wnt/β-catenin signaling pathway by inhibiting GSK3 activity, which is crucial for cell proliferation, differentiation, and synapse maintenance. Quercitrin's effects were demonstrated in various models, including cell assays and animal models like mice and Xenopus laevis, where it increased β-catenin stabilization and synaptogenesis. In mice, quercitrin rescued memory impairment and synapse loss induced by amyloid-β oligomers, suggesting its potential as a therapeutic candidate for Alzheimer's disease. The study highlighted quercitrin's ability to enhance Wnt signaling without promoting tumorigenesis, making it a promising candidate for further research in treating neurodegenerative diseases.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 48 results

    Similar Research

    5 / 591 results